Management of febrile neutropenia: ESMO clinical recommendations

Ann Oncol. 2009 May:20 Suppl 4:166-9. doi: 10.1093/annonc/mdp163.

Authors

F Marti Marti¹, M H Cullen, F Roila; ESMO Guidelines Working Group

Affiliation

¹ Department of Medical Oncology, University Hospital Birmingham, NHS Foundation Trust, Birmingham, UK.

PMID: 19454445
DOI: 10.1093/annonc/mdp163

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / adverse effects
Disease Management
Europe / epidemiology
Fever / chemically induced
Fever / therapy*
Health Planning Guidelines*
Humans
Neutropenia / chemically induced
Neutropenia / therapy*
Societies, Medical / standards*

Substances

Antineoplastic Agents